Evidence & concentration worksheet · Bioregulators
Chonluten 20 mg
Human efficacy and a validated dose have not been established for this compound. The former regimen has been withheld; only concentration arithmetic remains available.
Evidence review
No established human dosing protocol
Human efficacy and a validated dose have not been established for this compound. The former regimen has been withheld; only concentration arithmetic remains available.
How it works
Chonluten is a commercial name associated with the tripeptide EDG (Glu-Asp-Gly) and marketed for respiratory “bioregulation.” It has no FDA-approved product, respiratory indication, or dose.
Benefits & side effects
Published work has measured gene and protein expression in bronchial epithelial cultures and inflammatory responses in monocyte/macrophage cell systems.[1][2] These experiments do not show improved breathing, fewer exacerbations, infection treatment, fibrosis reversal, or clinical benefit in asthma or COPD.
Calculator
Concentration and measurement calculator
Use this only to check arithmetic from an authoritative product label, registered study protocol, or qualified clinician.
Arithmetic only — not a dose recommendation
Enter only a concentration and target supplied by an authoritative product label, a registered study protocol, or a qualified clinician. A correct conversion does not establish that a substance, vial, route, or dose is safe or effective.
Enter only a concentration and target supplied by an authoritative product label, a registered study protocol, or a qualified clinician. A correct conversion does not establish that a substance, vial, route, or dose is safe or effective.
Source concentration
Source-supplied target
References
References
- Lung — Peptide regulation of gene expression in bronchial epithelium (2014)
- International Journal of Molecular Sciences — Peptides in monocyte/macrophage cell-line inflammatory pathways (2022)
- U.S. FDA — Understanding the risks of compounded drugs (2026)